Gilat to Report Third Quarter 2024 Results on Wednesday, November 13th
PETAH TIKVA, Israel, Oct. 21, 2024 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader […]
Golar LNG Limited – Q3 2024 results presentation
Golar LNG’s 3rd Quarter 2024 results will be released before the NASDAQ opens on Tuesday, November 12, 2024. In connection […]
Li Auto Inc. to Report Third Quarter 2024 Financial Results on October 31, 2024
BEIJING, China, Oct. 21, 2024 (GLOBE NEWSWIRE) — Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), […]
Oculis Accelerates Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema and Expands its DIAMOND Program Committees
Phase 3 DIAMOND-1 and DIAMOND-2 trials enrollment of OCS-01 in diabetic macular edema (DME) accelerated with great momentum DIAMOND program […]
Niu Technologies to Report Third Quarter 2024 Financial Results on November 18, 2024
BEIJING, Oct. 21, 2024 (GLOBE NEWSWIRE) — Niu Technologies (“NIU” or “the Company”) (NASDAQ: NIU), the world’s leading provider of […]
InterDigital and The University of Texas at Austin to Showcase Over-the-Air Federated Learning for AI Model Training at Brooklyn 6G Summit
WILMINGTON, Del., Oct. 21, 2024 (GLOBE NEWSWIRE) — InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and […]
Verona Pharma to Report Third Quarter 2024 Financial Results and Provide Corporate Update
LONDON and RALEIGH, N.C., Oct. 21, 2024 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) […]
Nasdaq Confirms VEON’s Full Compliance Following its 2023 20-F Filing
Amsterdam and Dubai, 21 October 2024: VEON Ltd. (Nasdaq: VEON; Euronext Amsterdam: VEON), a global digital operator (“VEON” or the […]
NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)
SAN DIEGO, Oct. 18, 2024 (GLOBE NEWSWIRE) — Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing […]
Tevogen CEO Expresses Gratitude for Unprecedented Public Support of Company’s Business Model of Commercial Success Through Patient Accessibility and Reaffirms His Commitment to Share Additional Details in the Coming Days
WARREN, N.J., Oct. 18, 2024 (GLOBE NEWSWIRE) — Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN) is a […]
